MAPT and Alzheimer disease: From our in-house antibody collection, PT76, developed by immunization with human AD brain-derived PHF as first described in Vandermeeren et al. [13] was found to bind a Tau epitope encompassing residues 249–258 which is localized N-terminal from the MTBD.